Clopidogrel Dosing in Overweight Patients: Does One Size Fit All?

Journal of Invasive Cardiology

Volumn 16, Issue 4, 2004, Pages 175-176

  Patel, Manesh R ^b   Peterson, Eric D ^a  

^a DUKE CLINICAL RESEARCH INSTITUTE   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; CLOPIDOGREL; FIBRINOGEN RECEPTOR ANTAGONIST; TICLOPIDINE;

DOSE CALCULATION; DRUG EFFICACY; DRUG SAFETY; HEART MUSCLE REVASCULARIZATION; HUMAN; NOTE; OBESITY; THROMBOCYTE AGGREGATION INHIBITION; THROMBOSIS; TRANSLUMINAL CORONARY ANGIOPLASTY;

BLOOD VESSEL PROSTHESIS IMPLANTATION; BODY MASS INDEX; BODY WEIGHT; CORONARY STENOSIS; DOSE-RESPONSE RELATIONSHIP, DRUG; HUMANS; OBESITY; PLATELET AGGREGATION; PLATELET AGGREGATION INHIBITORS; STENTS; TICLOPIDINE;

EID: 1842476233     PISSN: 10423931     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Note

References (20)

1. Serruys PW, et al. A comparison of balloon-expandable-stent implantation with balloon angioplasty in patients with coronary artery disease. Benestent Study Group. N Engl J Med 1994;331:489-495.
2. Fischman DL, et al. A randomized comparison of coronary-stent placement and balloon angioplasty in the treatment of coronary artery disease. Stent Restenosis Study Investigators. N Engl J Med 1994;3318:496-501.
3. Shaknovich, A. Complications of coronary stenting. Coron Art Dis 1994;5:583-589.
4. Leon MB, et al. A clinical trial comparing three antithrombotic-drug regimens after coronary-artery stenting. Stent Anticoagulation Restenosis Study Investigators. N Engl J Med 1998;339:1665-1671.
5. Schomig A, et al. A randomized comparison of antiplatelet and anticoagulant therapy after the placement of coronary-artery stents. N Engl J Med 1996;334:1084-1089.
6. Urban P, et al. Randomized evaluation of anticoagulation versus antiplatelet therapy after coronary stent implantation in high-risk patients: the multicenter aspirin and ticlopidine trial after intracoronary stenting (MATTIS). Circulation 1998;98:2126-2132.
7. Bertrand ME, et al. Double-blind study of the safety of clopidogrel with and without a loading dose in combination with aspirin compared with ticlopidine in combination with aspirin after coronary stenting: the clopidogrel aspirin stent international cooperative study (CLASSICS). Circulation 2000;102:624-629.
8. Bhatt DL, et al. Meta-analysis of randomized and registry comparisons of ticlopidine with clopidogrel after stenting. J Amer Coll Cardiol 2002;39:9-14.
9. Berger PB, et al. Clopidogrel versus ticlopidine after intracoronary stent placement. [see comment]. J Amer Coll Cardiol 1999;34:1891-1894.
10. Steinhubl SR, et al. Ticlopidine pretreatment before coronary stenting is associated with sustained decrease in adverse cardiac events: Data from the Evaluation of Platelet IIb/IIIa Inhibitor for Stenting (EPISTENT) Trial. Circulation 2001;103:1403-1409.
11. Mehta SR, et al. Effects of pretreatment with clopidogrel and aspirin followed by long-term therapy in patients undergoing percutaneous coronary intervention: The PCI-CURE study [See comment]. Lancet 2001;358:527-533.
12. Gurbel PA, et al. Onset and extent of platelet inhibition by clopidogrel loading in patients undergoing elective coronary stenting: The Plavix Reduction of New Thrombus Occurrence (PRONTO) Trial. Amer Heart J 2003;145:239-247.
13. Steinhubl SR, et al. Early and sustained dual oral antiplatelet therapy following percutaneous coronary intervention: a randomized controlled trial. [See comment] [Erratum appears in J Amer Med Assoc. 2003;289:987]. J Amer Med Assoc 2002;288:2411-2420.
14. Steinhubl SR, et al. Early and sustained dual oral antiplatelet therapy following percutaneous coronary intervention: a randomized controlled trial. [See comment] [Erratum appears in J Amer Med Assoc. 2003;289:987]. J Amer Med Assoc 2002;288:2411-2420.
15. Kastrati A, et al. A clinical trial of abciximab in elective percutancous coronary intervention after pretreatment with clopidogrel. N Engl J Med 2004;350:232-238.
16. Seyfarth HJ, et al. Effect of 300- and 450-mg clopidogrel loading doses on membrane and soluble P-selectin in patients undergoing coronary stent implantation. Amer Heart J 2002;143:118-123.
17. Pache J, et al. Clopidogrel therapy in patients undergoing coronary stenting: value of a high-loading-dose regimen. Cathet Cardiovasc Interven 2002;55:436-441.
18. Gurbel PA, et al. Clopidogrel for coronary stenting: response variability, drug resistance, and the effect of pretreatment platelet reactivity. Circulation 2003;107:2908-2913.
19. Lau WC, et al. Atorvastatin reduces the ability of clopidogrel to inhibit platelet aggregation: A new drug-drug interaction. Circulation 2003;107:32-37.
20. Neubauer H, et al. Lipophilic statins interfere with the inhibitory effects of clopidogrel on platelet function: A flow cytometry study. Eur Heart J 2003;24:1744-1749.